C-peptide


Also found in: Medical, Wikipedia.

C-peptide

[¦sē ′pep‚tīd]
(biochemistry)
A metabolically inactive polypeptide chain that is a by-product of normal insulin production by the beta cells in the pancreas.
References in periodicals archive ?
Correlations between fasting plasma C-peptide, glucagon-stimulated plasma C-peptide, and urinary C-peptide in insulin-treated diabetics.
reuteri had increased glucose-stimulated insulin secretion by 49%, C-peptide secretion by 55%, GLP-1 release by 76%, GLP-2 release by 43%, and altered beta-cell function relative to people taking the placebo.
C-peptide levels of these samples were measured by Iodine [125I] C-peptide Radio-immunoassay Kit (Beijing North Institute of Biological Technology, Product lot: 20110215, Beijing, China) according to the manufacturer's instructions.
com)-- ALPCO announced the launch of its new STELLUX[R] Chemiluminescent Human C-peptide ELISA on December 5, 2014.
6 U/mL (reference: <1 U/mL)] and postprandial C-peptide concentrations were undetectable.
The authors of the research said that eating only whole breakfast and lunch helps in reducing body weight, liver fat content, fasting plasma glucose, C-peptide and glucagon and improved OGIS, more than the six meals split into same caloric restriction.
Glycated haemoglobin (GlycoHb) levels, plasma insulin, and serum C-peptide levels were measured after 4 and 8 weeks of NAG treatment.
Note that according to the American Diabetes Association (ADA), neither insulin nor C-peptide is used for the diagnosis or classification of diabetes.
Because the participants received daily insulin injections before and throughout the trial, researchers instead monitored their blood levels of C-peptide, a molecule produced in the pancreas at the same rate as insulin.
They also had greater decreases in fasting plasma glucose, C-peptide, glucagon, and hepatic fat content, and bigger improvements in insulin sensitivity.
The meta-analysis, which included 40 published studies and 56,111 women with breast cancer, found no association between risk of the malignancy and circulating serum insulin level, insulin growth factor-1 level, fasting blood glucose level, or C-peptide concentration.
Thirty-eight Brazilian patients (mean age, 13 years) with new-onset type 1 diabetes and a fasting C-peptide level [greater than or equal to]0.